High Net Worth Advisory Group LLC Provention Bio, Inc. Transaction History

High Net Worth Advisory Group LLC

  • $358 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.52 - $10.57 $1,355 - $3,171
300 New
300 $3,000
Q2 2022

Aug 10, 2022
SELL
$3.65 - $7.3 $9,125 - $18,250
-2,500 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$3.4 - $7.88 $5,100 - $11,820
1,500 Added 150.0%
2,500 $18,000
Q4 2021

Apr 27, 2022
BUY
$5.59 - $7.39 $5,590 - $7,390
1,000 New
1,000 $5,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track High Net Worth Advisory Group LLC Portfolio

Follow High Net Worth Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Net Worth Advisory Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email